UA97360C2 - Antibodies to egfl7 and methods for their use - Google Patents

Antibodies to egfl7 and methods for their use

Info

Publication number
UA97360C2
UA97360C2 UAA200812195A UAA200812195A UA97360C2 UA 97360 C2 UA97360 C2 UA 97360C2 UA A200812195 A UAA200812195 A UA A200812195A UA A200812195 A UAA200812195 A UA A200812195A UA 97360 C2 UA97360 C2 UA 97360C2
Authority
UA
Ukraine
Prior art keywords
egfl7
antibody
pta
subject
antibodies
Prior art date
Application number
UAA200812195A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Вейлань Е
Майке ШМИДТ
Джо-энн ХОНГО
Янь У
Original Assignee
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Инк. filed Critical Дженентек, Инк.
Priority claimed from PCT/US2007/064242 external-priority patent/WO2007106915A2/en
Publication of UA97360C2 publication Critical patent/UA97360C2/en

Links

Abstract

The present invention relates to an antibody against Epidermal Growth Factor-Like Domain 7 (EGFL7) produced by the hybridoma selected from the group PTA-7343, PTA-7344, PTA-7345. The invention further relates to a pharmaceutical composition comprising an anti-EGFL7 antibody, a polynucleotide encoding an antibody, a vector, a host cell, a method for making an anti-EGFL7 antibody, a method for reducing or inhibiting angiogenesis in a subject, a method of enhancing the efficacy of an anti-angiogenic agent in a subject having a pathological condition.
UAA200812195A 2006-03-16 2007-03-16 Antibodies to egfl7 and methods for their use UA97360C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78368606P 2006-03-16 2006-03-16
PCT/US2007/064242 WO2007106915A2 (en) 2006-03-16 2007-03-16 Antibodies to egfl7 and methods for their use

Publications (1)

Publication Number Publication Date
UA97360C2 true UA97360C2 (en) 2012-02-10

Family

ID=40727139

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200812195A UA97360C2 (en) 2006-03-16 2007-03-16 Antibodies to egfl7 and methods for their use

Country Status (3)

Country Link
CN (1) CN101443359A (en)
UA (1) UA97360C2 (en)
ZA (1) ZA200807225B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI560199B (en) * 2010-08-31 2016-12-01 Sanofi Sa Peptide or peptide complex binding to α2 integrin and methods and uses involving the same
EP2831093A4 (en) * 2012-03-27 2015-11-04 London Health Sci Ct Res Inc Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
CN112300284B (en) * 2020-12-29 2021-04-06 慈达(广州)生物技术有限公司 Application of nucleic acid screening and antibody detection in cancer detection and kit prepared by same

Also Published As

Publication number Publication date
CN101443359A (en) 2009-05-27
ZA200807225B (en) 2009-11-25

Similar Documents

Publication Publication Date Title
UA96141C2 (en) Neutralising antibody having specificity for human il-6
WO2010129609A3 (en) Antibodies and methods of use thereof
MX2014012824A (en) Foam or viscosified composition containing a chelating agent.
SG169988A1 (en) Rnai inhibition of alpha-enac expression
MY163193A (en) Process and fluid to improve the permeability of sandstone formations using a chelating agent
WO2010088517A8 (en) Methods and systems for purifying transferring and/or manipulating nucleic acids
TW200714289A (en) Treatment of bone disorders
SG179158A1 (en) Composition and method for polishing bulk silicon
MY153710A (en) Humanized c-kit antibody
MX2010004219A (en) Cd19 binding agents and uses thereof.
WO2011079902A3 (en) Biological inhibitors of ror1 capable of inducing cell death
WO2008154249A3 (en) Gene expression markers of tumor resistance to her2 inhibitor treatment
EP2493507A4 (en) Ax213 and ax132 pcsk9 antagonists and variants
WO2011031920A3 (en) Process of using hard brine at high alkalinity for enhanced oil recovery (eor) applications
MX2009004532A (en) Compositions and methods for binding sphingosine-1-phosphate.
ATE533838T1 (en) METHOD FOR IMPROVED INTRODUCTION OF DNA INTO BACTERIAL CELLS
MX2009008698A (en) Arabinoxylo-oligosaccharides in beer.
WO2012160563A3 (en) Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
WO2010042636A3 (en) Telomerase inhibitors and methods of use thereof
BR112013002738A2 (en) methods and compounds for cancer diagnosis and treatment
WO2007106915A8 (en) Antibodies to egfl7 and methods for their use
WO2010033586A3 (en) Use of hydroxycarboxylates for water hardness control
MY162994A (en) Composition and method for polishing bulk silicon
UA97360C2 (en) Antibodies to egfl7 and methods for their use
EP2594274A4 (en) Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof